Company: PTHS
Filing Date: 2025-11-25
Form Type: DEF 14A
Source: 0001753926-25-001827
Chunk: 3

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-11-25
Form: DEF 14A
Chunk 3
---
 Treasurer and Secretary, and Scott Plesha is our Chief Executive Officer and each will vote all shares represented by properly executed proxies returned in time to be counted at the Annual Meeting, as described below under “ Voting Procedures and Vote Required.” Where a vote has been specified in the proxy with respect to the matters identified in the Notice of Internet Availability, the shares represented by the proxy will be voted in accordance with those voting specifications. If no voting instructions are indicated, your shares will be voted as recommended by the Board on all matters and as the proxy holders may determine in their discretion with respect to any other matters properly presented for a vote before the Annual Meeting.

The shareholders will consider and vote
upon (i) a proposal to elect seven (7) members of the Board, each to serve until the Company’s 2025 Annual Meeting of Shareholders
and until each of their respective successors are elected and qualified or until each of their earlier resignation or removal (“Proposal
No. 1”); (ii) a proposal to waive the limit on the number of shares of Common Stock that may be issued to certain the
holders of the Company’s Senior Secured Convertible Notes (the “Convertible Notes”) pursuant to the NYSE American
LLC (the “NYSE American”), which requires shareholder approval before issuing common stock (or securities convertible
into or exercisable for common stock) in a private placement that constitutes 20% or more of the Company’s pre-transaction
outstanding common stock (“Proposal No. 2”); and (iii) a proposal to ratify the Board’s selection of CBIZ CPAs
P.C. (“CBIZ”) as the Company’s independent registered public accountants for the fiscal year ending December 31,
2025 (“Proposal No. 3”). Shareholders also will consider and act upon such other business as may properly come before
the Annual Meeting.

<div align='center'>1</div>

Voting Procedures and Vote Required

Mr. Knuettel and Mr. Plesha will vote all shares represented by properly executed proxies returned in time to be counted at the Annual Meeting. The presence, via internet or by proxy, of one-third of the votes which could be cast by the holders of all outstanding shares of Common Stock entitled to vote at the Annual Meeting is necessary to establish a quorum for the transaction of business. In the absence of a quorum and until a quorum is secured, a majority of the shareholders who are present in person or by proxy may adjourn the meeting